Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study.

Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P.

Clin J Pain. 2006 Jul-Aug;22(6):526-31.

PMID:
16788338
2.

The impact of topiramate on health-related quality of life indicators in chronic migraine.

Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.

Headache. 2007 Nov-Dec;47(10):1398-408.

PMID:
18052949
3.

Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.

Nickel C, Lahmann C, Tritt K, Muehlbacher M, Kaplan P, Kettler C, Krawczyk J, Loew TH, Rother WK, Nickel MK.

J Affect Disord. 2005 Aug;87(2-3):243-52.

PMID:
15985295
4.

Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH.

Biol Psychiatry. 2005 Mar 1;57(5):495-9.

PMID:
15737664
5.

Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.

Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J; CAPSS-277 Investigator Group.

Clin Ther. 2009 Mar;31(3):542-59. doi: 10.1016/j.clinthera.2009.03.020.

PMID:
19393844
6.

Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.

Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.

Headache. 2009 Sep;49(8):1153-62. doi: 10.1111/j.1526-4610.2009.01508.x.

PMID:
19719543
7.

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.

Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.

Health Qual Life Outcomes. 2007 Oct 4;5:56.

8.

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group.

Cephalalgia. 2007 Jul;27(7):814-23. Epub 2007 Apr 18. Erratum in: Cephalalgia. 2007 Aug;27(8):962.

PMID:
17441971
9.

Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial.

Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, Lahmann C, Leiberich PK, Krawczyk J, Kettler C, Rother WK, Loew TH, Nickel MK.

Int J Eat Disord. 2005 Dec;38(4):295-300.

PMID:
16231337
10.
11.

Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.

Katz N, Ju WD, Krupa DA, Sperling RS, Bozalis Rodgers D, Gertz BJ, Gimbel J, Coleman S, Fisher C, Nabizadeh S, Borenstein D; Vioxx Chronic Low Back Pain Study Group.

Spine (Phila Pa 1976). 2003 May 1;28(9):851-8; discussion 859.

PMID:
12941996
12.

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.

Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J; TOPMAT-MIG-303 Investigators Group.

Lancet Neurol. 2007 Dec;6(12):1054-62. Epub 2007 Nov 7. Erratum in: Lancet Neurol. 2008 Jan;7(1):25.

PMID:
17988947
13.

Efficacy and safety of duloxetine in patients with chronic low back pain.

Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, Iyengar S, Atkinson JH, Backonja M.

Spine (Phila Pa 1976). 2010 Jun 1;35(13):E578-85. doi: 10.1097/BRS.0b013e3181d3cef6.

PMID:
20461028
14.

Efficacy of tramadol in treatment of chronic low back pain.

Schnitzer TJ, Gray WL, Paster RZ, Kamin M.

J Rheumatol. 2000 Mar;27(3):772-8.

PMID:
10743823
15.

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.

Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.

Headache. 2012 Jan;52(1):57-67. doi: 10.1111/j.1526-4610.2011.02027.x. Epub 2011 Nov 11.

PMID:
22078129
16.

Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up.

Nickel MK, Loew TH.

Eur Psychiatry. 2008 Mar;23(2):115-7. Epub 2007 Nov 19.

PMID:
18024088
17.

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; Topiramate Chronic Migraine Study Group.

Headache. 2007 Feb;47(2):170-80.

PMID:
17300356
18.

Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.

Connor GS, Edwards K, Tarsy D.

Clin Neuropharmacol. 2008 Mar-Apr;31(2):97-103. doi: 10.1097/WNF.0b013e3180d09969.

PMID:
18382182
19.

A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back pain.

Yarlas A, Miller K, Wen W, Dain B, Lynch SY, Pergolizzi JV, Raffa RB, Ripa SR.

J Pain. 2013 Jan;14(1):14-23. doi: 10.1016/j.jpain.2012.09.016. Epub 2012 Nov 29.

PMID:
23200931
20.

Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.

Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.

Clin Neuropharmacol. 2006 Sep-Oct;29(5):269-75.

PMID:
16960472

Supplemental Content

Support Center